Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes
Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes
GlobeNewswire –

Company announcement – No. 54 / 2026 Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes Petrelintide achieved up to 9.2% mean body…

statnews.com - Ed Silverman - Pharmalittle: We're reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
Pharmalittle: We're reading about WHO obesity guidelines for kids, DOJ targeting pharma, and more
STAT –

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you…

marketbeat.com - NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Stock Has Consensus Target Price of $49.00 According to Analysts
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Stock Has Consensus Target Price of $49.00 According to Analysts
MarketBeat –

Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) have been given a consensus recommendation of 'Moderate Buy' by the thirteen brokerages that are presently covering the stock, Marketbeat.com reports. One analyst has rated…

marketbeat.com - 527,094 Shares of Royalty Pharma PLC $RPRX Bought by Congress Asset Management Co.
527,094 Shares of Royalty Pharma PLC $RPRX Bought by Congress Asset Management Co.
MarketBeat –

Congress Asset Management Co. bought a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 527,094 shares of…

independent.co.uk - Deena Beasley - AI companies see success in predicting drug failures after virtual human trials
AI companies see success in predicting drug failures after virtual human trials
The Independent –

A late-stage clinical trial for Novartis ' experimental muscular dystrophy treatment del-desiran failed to meet its primary objective last month, causing the Swiss pharmaceutical company's market value to fall by $30 billion as shares dropped 11%.

forbes.com - Jennifer Waters - Client Intimacy: The Secret Sauce For Exceptional Service At Scale
Client Intimacy: The Secret Sauce For Exceptional Service At Scale
Forbes –

Jennifer Waters, SVP at BioCareSD, is a leading voice in specialty pharma, championing transparency and industry innovation. ​Growth is supposed to make a company better. More customers. More employees. More resources. More market power. Yet…

globenewswire.com - Orion Oyj - 125,000 Orion Corporation A shares converted into B shares
125,000 Orion Corporation A shares converted into B shares
GlobeNewswire –

STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 125,000 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 125,000…

seekingalpha.com - Albert Anthony - AvePoint Rides AI-Driven Tailwind, Proving Itself As A Durable Cash Flow Engine (AVPT)
AvePoint Rides AI-Driven Tailwind, Proving Itself As A Durable Cash Flow Engine (AVPT)
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

marketbeat.com - Top Healthcare Stocks To Watch Now - October 7th
Top Healthcare Stocks To Watch Now - October 7th
MarketBeat –

Medtronic's Stars Are Aligning for a Price Recovery Medtronic, Moderna, Eli Lilly and Company, Natera, UnitedHealth Group, Thermo Fisher Scientific, and Twist Bioscience are the seven Healthcare stocks to watch today, according to MarketBeat's…

teenvogue.com - Kelsey Stiegman - Fashion Week's Response to AI Fatigue? A Distinctly Human Sloppiness
Fashion Week's Response to AI Fatigue? A Distinctly Human Sloppiness
Teen Vogue –

The Spring/Summer 2027 runways were rife with what could be considered fashion mishaps: belts left unbuckled, bras slung over shoulders, satin slip dresses half pulled up. In reality, however, these were clothes portrayed as life actually demands…

slate.com - Daniel Strauss - A Progressive Democrat Tried to Woo MAHA Republicans. The Early Response Is Revealing.
A Progressive Democrat Tried to Woo MAHA Republicans. The Early Response Is Revealing.
Slate –

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. Locked in a tight Senate race in Michigan, progressive Democrat Abdul El-Sayed is vying for every vote he can…

fool.com - Keith Speights - Warren Buffett's Favorite Valuation Indicator Blew Past the Level He Warned Was 'Playing With Fire.' Here Are 3 Stocks Still Cheap Enough to Buy.
Warren Buffett's Favorite Valuation Indicator Blew Past the Level He Warned Was 'Playing With Fire.' Here Are 3 Stocks Still Cheap Enough to Buy.
The Motley Fool –

What's the best valuation metric for the stock market? Warren Buffett weighed in with his answer years ago. The legendary investor wrote in a 2001 Fortune article that the ratio of total market capitalization to gross national product (GNP), which…

channelnewsasia.com - Juliana Liu - Commentary: Keep medicine out of the US-China tech war
Commentary: Keep medicine out of the US-China tech war
CNA –

HONG KONG: As Washington and Beijing tussle for dominance in frontier technologies, there's one area in which competition shouldn't preclude collaboration: innovative medicines. Beijing's latest five-year plan for the biotechnology sector details…

cityam.com - Felix Armstrong - Billionaire Weston family buys Boots for $9bn
Billionaire Weston family buys Boots for $9bn
City AM –

The billionaire Weston family has struck a deal to buy Boots for nearly $9bn, scuppering hopes that the high street giant could return to the London Stock Exchange. Wittington Investments, the holding company for the Westons' Canadian operations…

cyprus-mail.com - Medochemie receives top honour at Cyprus environmental awards
Medochemie receives top honour at Cyprus environmental awards
Cyprus Mail –

Pharmaceutical company Medochemie received the Golden Cedar, the highest special distinction at the Cyprus Environmental Awards for Organisations and Businesses, after achieving the highest overall score among all nominees and categories, the…

Receive a Daily briefing on Pharma Industry News

Get Started